Ann: Trading Halt, page-64

First 64 Last

Share
Profile

Follow
Torbreck

12,643 Posts.

527

10/12/20

09:30

Post #: 49473472
Share

Originally posted by possum2: ↑

Chief,

""Cleary I’m not wrapped about the timing of CR but Jesus the way a few are carrying on youd think this mob just went belly up. ""

In relation to cap raisings one of the responsibilities management has, is to raise money at the best possible price it can, to avoid unnecessary dilution.
Timing is everything when trying to maximise the best possible price. ECS was on the verge of having a serious breakout yesterday and shareholders who have been holding on for a very long time were robbed of a major pay day. CPH managed to climb to 47c yesterday on the back of 537 million shares traded. A 100% rise during the day compared to where it finished the night before. That is some rise when you consider it had already gone up 8 times in the past couple of weeks. What a ride it has been and for those shareholders who have been patient they finally got rewarded in spades..
One can only guess what share price appreciation ECS would have experienced given it's low market cap and the very strong day before the trading halt. 213 million shares traded the day before the Halt was announced . Only 30 million traded the day before that. So I guess it's fair to say the market had signalled it was ready to give ECS a major re rating.

Management made a mistake by not reading the market correctly with a series of MAJOR ANNOUNCEMENTS made recently that will change the cannabis landscape forever.
Whatever the cap raising is, at whatever the price, I would suggest to you that half of the amount of shares issued in this raising could have been achieved with the same money raised which ultimately has a major impact on the dilution effect. If I am a long term shareholder in any company I expect management to act in my best interests . This was not achieved in my opinion.

Given one of the directors was an ex broker makes the timing even more confusing. One would have thought he would have been able to read the present interest in cannabis stocks much clearer.

An opportunity was clearly lost.

Cheers.

Expand

What happens if ECS goes up 100% after the CR? Opportunity missed? Who knows what will happen by the end of the week

ECS Price at posting: 6.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

There are more pages in this discussion • 38 more messages in this thread...

First 64 Last

Add ECS (ASX) to my watchlist

(20min delay)
Last 1.8¢		Change -0.001(2.70%)		Mkt cap ! $23.19M

Open	High	Low	Value	Volume
1.7¢	1.8¢	1.7¢	$13.40K	749.1K

Buyers (Bids)

No.	Vol.	Price($)
2	30865	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	1279773	4

View Market Depth

No.	Vol.	Price($)
2	30865	0.018
12	4088522	0.017
17	6486172	0.016
16	6877639	0.015
6	1891428	0.014

Price($)	Vol.	No.
0.019	1279773	4
0.020	818251	8
0.021	1563441	4
0.022	920000	4
0.023	578677	2

Last trade - 16.10pm 02/10/2024 (20 minute delay)

ECS (ASX) Chart

Ann: Trading Halt, page-64

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-64

Top Stories

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News